Milford, MA · Founded 2018 · Privately Held (backing)
Developer of an acute decompensated heart failure (ADHF) treatment medical device designed to help patients experience life without limits. Reprieve Cardiovascular is based in Milford, MA and was founded in 2018. It was valued at $100 million at its later-stage round in Sep 2025, the last priced event on record. It has raised $103 million across 5 recorded rounds; the latest was a $30.9 million early-stage round in May 2025.
PMV mark · valuation
$100.0M
Oct 2026
Priced at
its later-stage round
Sep 2025
Total raised
$103.0M
Last round
Early Stage VC
May 2025
Cap table — not yet on record
Reprieve Cardiovascular's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Reprieve Cardiovascular with a free account
·The complete investor list: 11 names
·Watch Reprieve Cardiovascular: the Monday email on marks, rounds and moves
Where does Reprieve Cardiovascular's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Reprieve Cardiovascular's 5 recorded funding rounds.
